Paradeep Phosphates Intrinsic Value
PARADEEP • Chemicals
Current Stock Price
₹121.25
Primary Intrinsic Value
₹158.40
Market Cap
₹9882 Cr
+30.2%
Upside
Median Value
₹157.88
Value Range
₹50 - ₹243
Assessment
Trading Below Calculated Value
Safety Margin
23.2%
PARADEEP Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹158.40 | ₹126.72 - ₹190.08 | +30.6% | EPS: ₹13.20, Sector P/E: 12x |
| Book Value Method | asset | ₹50.02 | ₹45.02 - ₹55.02 | -58.7% | Book Value/Share: ₹50.02, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹242.50 | ₹218.25 - ₹266.75 | +100.0% | Revenue/Share: ₹339.34, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹205.55 | ₹185.00 - ₹226.11 | +69.5% | EBITDA: ₹2792.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹157.88 | ₹126.30 - ₹189.46 | +30.2% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹84.48 | ₹76.03 - ₹92.93 | -30.3% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹108.77 | ₹97.89 - ₹119.65 | -10.3% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹242.50 | ₹218.25 - ₹266.75 | +100.0% | ROE: 33.6%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹100.05 | ₹90.05 - ₹110.06 | -17.5% | EPS: ₹13.20, BVPS: ₹50.02 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
PARADEEP Intrinsic Value Analysis
What is the intrinsic value of PARADEEP?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Paradeep Phosphates (PARADEEP) is ₹157.88 (median value). With the current market price of ₹121.25, this represents a +30.2% variance from our estimated fair value.
The valuation range spans from ₹50.02 to ₹242.50, indicating ₹50.02 - ₹242.50.
Is PARADEEP undervalued or overvalued?
Based on our multi-method analysis, Paradeep Phosphates (PARADEEP) appears to be trading below calculated value by approximately 30.2%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 8.45 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 33.6% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 10.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.48x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Paradeep Phosphates
Additional stock information and data for PARADEEP
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹1,386 Cr | ₹1,088 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹1,437 Cr | ₹1,254 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-2,377 Cr | ₹-2,587 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-44 Cr | ₹-594 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹1,501 Cr | ₹1,357 Cr | Positive Free Cash Flow | 8/10 |